Phase 2

DNTH103A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy

Sponsor:

Dianthus Therapeutics

Code:

NCT06537999

Conditions

Multifocal Motor Neuropathy

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Claseprubart

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-26. This information was provided to ClinicalTrials.gov by Dianthus Therapeutics on 2026-08-10.